Could Inovio Win On This 1 Vaccine Detail?

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Mar 8, 2022 at 10:42 AM.

  1. cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    33,039
    Likes Received:
    3
    via Inovio Pharmaceuticals( INO -1.90% ) was an early star in the coronavirus vaccine race. In the first half of 2020, its shares soared more than 700%. But the company fell behind in its development timeline. One major hurdle was a partial clinical hold on one of its trials. And the stock's performance has struggled since. It's down more than 80% from its 2020 peak.

    article source